Pyxis Oncology
PYXS
PYXS
72 hedge funds and large institutions have $97.8M invested in Pyxis Oncology in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
41% more funds holding
Funds holding: 51 → 72 (+21)
19.63% more ownership
Funds ownership: 19.85% → 39.48% (+20%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
72
Holding in Top 10
2
Calls
$543K
Puts
$203K
Top Buyers
| 1 | +$17.8M | |
| 2 | +$11.1M | |
| 3 | +$7.64M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.08M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$2.94M |
Top Sellers
| 1 | -$920K | |
| 2 | -$792K | |
| 3 | -$438K | |
| 4 |
Two Sigma Advisers
New York
|
-$207K |
| 5 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
-$201K |